{"id":"W2440371401","doi":"10.1111/ajco.12513","title":"An East Asian subgroup analysis of PROCLAIM, a phase III trial of pemetrexed and cisplatin or etoposide and cisplatin plus thoracic radiation therapy followed by consolidation chemotherapy in locally advanced nonsquamous non–small cell lung cancer","year":2016,"lang":"en","type":"article","venue":"Asia-Pacific Journal of Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Pemetrexed; Medicine; Cisplatin; Hazard ratio; Etoposide; Internal medicine; Oncology; Carboplatin; Chemotherapy; Confidence interval; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001816112,0.0002594528,0.002191872,0.000486313,0.00003795605,0.00001262196,0.0001178956,0.0003468659,0.0001147441],"category_scores_gemma":[0.0002829299,0.000160383,0.0003108101,0.0005814107,0.0002399209,0.0001936146,0.00001402123,0.0002945246,2.303253e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003676099,"about_ca_system_score_gemma":0.00132745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008654181,"about_ca_topic_score_gemma":0.0006843645,"domain_scores_codex":[0.9960456,0.0004921083,0.002449912,0.0004035752,0.0003464394,0.0002623758],"domain_scores_gemma":[0.9953429,0.001229834,0.00251579,0.0002644633,0.0003433903,0.0003036856],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2577731,0.005190881,0.1505274,0.00008386894,0.001722739,0.00007802288,0.001382488,0.0000225076,0.01713973,0.000005904697,0.0002839694,0.5657894],"study_design_scores_gemma":[0.7843654,0.07167748,0.1108252,0.0008845569,0.006019115,0.00006302776,0.001981855,0.003679918,0.01862021,0.0000349746,0.001373038,0.0004752253],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924435,0.00120193,0.001145294,0.003282383,0.00023167,0.001428626,0.00005526327,0.000006400496,0.0002049312],"genre_scores_gemma":[0.9896725,0.008388663,0.001460569,0.0001292842,0.0001440399,0.00006854685,0.00002381853,0.00002643508,0.00008607562],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5653142,"threshold_uncertainty_score":0.6540229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03462318452454766,"score_gpt":0.4324831263084926,"score_spread":0.397859941783945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}